Mild cases of diarrhea are treated with Bismuth subsalicylate (trade name Pepto-Bismol); extreme cases are treated with fluid and electrolyte replacement while the underlying disease passes.
The feeling is that donanemab will get FDA approval before the end of this year and then it, too, will get a trade name or brand name, which I hope is easier to remember and pronounce than donanemab.